Introducing inhibitors of bone morphogenic proteins along with basic fibroblast growth factor (bFGF) into culture medium for human embryonic stem (ES) cells facilitates long-term maintenance of these cells in the pluripotent state, coming one step closer to the goal of a fully defined system for human ES cell (hESC) culture free of animal products.